| P2093 | author name string | B J Kullberg | |
| | M G Netea | |
| | J W Van der Meer | |
| | J Van der Ven-Jongekrijg | |
| | M W Bleeker | |
| P2860 | cites work | Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 |
| | Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro | Q28378754 |
| | Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia | Q34173960 |
| | Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms | Q35585405 |
| | Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia | Q40721842 |
| | Pathogenetic mechanisms of septic shock | Q40900222 |
| | Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids | Q41283123 |
| | Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock | Q41837133 |
| | Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor | Q41839655 |
| | A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits | Q43740171 |
| | Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes | Q44124013 |
| | Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor | Q44515935 |
| | Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. | Q48117114 |
| | Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. | Q54661310 |
| | Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo | Q60342761 |
| | Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes | Q68290258 |
| | The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro | Q69742371 |
| | Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man | Q70568911 |
| | Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor | Q70871432 |
| | Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production | Q70984018 |
| | Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings* | Q71968192 |
| | Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice | Q72227813 |
| | Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice | Q72515441 |
| P433 | issue | 4 | |
| P921 | main subject | chlorpromazine | Q407972 |
| | dexamethasone | Q422252 |
| P304 | page(s) | 548-552 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers | |
| P478 | volume | 91 | |